Public Company Edition: NewAmsterdam grossed $328m in its SPAC merger, while Liminatus may raise up to $316m in a new SPAC deal. Also, Intellia and Iveric grossed $300m each in follow-on offerings, bluebird sold a PRV for $102m and MEI ends zandelisib development resulting in layoffs.

PharmAsia News takes a closer look at presentations by Abbott, Amgen, Medtronic, Mylan, Shire, Stryker and Valeant.

ERSP clarifies requirements for quantified claims; food, veterinary medicine under same FDA office; FDA hosts forum on food safety regs; FDA OKs Reddy’s pediatric Allegra equivalent; Valeant finalizes Natur Produkt acquisition; FTC Chairman Jon Leibowitz to step down.

Steinford heads Doctor’s Best; NattoPharma names Vik CEO; Valeant President De Silva departing; Bayer’s Wenning moves to supervisory board chair; GMA strengthens federal affairs team; more People In Brief.